CVKD - CIK 0001937993
Cadrenal Therapeutics, Inc. has filed 237 documents with the SEC between 2022 and 2026. The most frequent type is major company event (50 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Employee stock plan | S-8 | 2023-01-24 | - |
| 424B4 | - | 2023-01-23 | - |
| 424B4 | - | 2023-01-23 | - |
| SEC STAFF LETTER | - | 2023-01-20 | - |
| Exchange certification | CERT | 2023-01-20 | - |
| EFFECT | - | 2023-01-19 | - |
| New insider ownership | 3 | 2023-01-19 | 2023-01-19 |
| New insider ownership | 3 | 2023-01-19 | 2023-01-19 |
| New insider ownership | 3 | 2023-01-19 | 2023-01-19 |
| New insider ownership | 3 | 2023-01-19 | 2023-01-19 |
| New insider ownership | 3 | 2023-01-19 | 2023-01-19 |
| New insider ownership | 3 | 2023-01-19 | 2023-01-19 |
| 8-A12B | - | 2023-01-17 | - |
| Company correspondence | CORRESP | 2023-01-17 | - |
| Company correspondence | CORRESP | 2023-01-17 | - |
| S-1/A | - | 2023-01-17 | - |
| S-1/A | - | 2022-12-28 | - |
| Company correspondence | CORRESP | 2022-12-08 | - |
| S-1/A | - | 2022-12-08 | - |
| D | - | 2022-12-08 | - |
| SEC correspondence | UPLOAD | 2022-12-08 | - |
| S-1/A | - | 2022-12-06 | - |
| Company correspondence | CORRESP | 2022-10-17 | - |
| S-1/A | - | 2022-10-17 | - |
| SEC correspondence | UPLOAD | 2022-10-13 | - |
| SEC STAFF LETTER | - | 2022-10-12 | - |
| S-1/A | - | 2022-10-11 | - |
| Company correspondence | CORRESP | 2022-09-22 | - |
| IPO registration | S-1 | 2022-09-22 | - |
| DRSLTR | - | 2022-09-02 | - |
| DRS/A | - | 2022-09-02 | - |
| SEC correspondence | UPLOAD | 2022-08-30 | - |
| DRSLTR | - | 2022-08-23 | - |
| DRS/A | - | 2022-08-23 | - |
| SEC correspondence | UPLOAD | 2022-08-11 | - |
| D | - | 2022-07-25 | - |
| DRS | - | 2022-07-15 | - |